These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18783701)

  • 1. [Acute cholestatic hepatitis due to propylthiouracil].
    Moral Moral P; Rodríguez Soler M; Mancheño Franch N; Aguilera Sánchez-Tello V; Todolí Parra J; Ponce García J; Calabuig Alborch JR
    Gastroenterol Hepatol; 2008; 31(7):474-5. PubMed ID: 18783701
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute cholestatic hepatitis induced by propylthiouracil. Case report].
    Parolin MB; Lopes RW; Telles JE; Ioshii SO; Hajar N
    Arq Gastroenterol; 2000; 37(2):129-32. PubMed ID: 11144016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholestatic hepatitis secondary to propylthiouracil].
    Cofré C; Valdés E; Tapia A; Rodríguez J
    Rev Med Chil; 1986 Jan; 114(1):42-4. PubMed ID: 3764142
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe hepatotoxicity on beginning propylthiouracil therapy.
    Lock DR; Sthoeger ZM
    J Clin Gastroenterol; 1997 Jun; 24(4):267-9. PubMed ID: 9252857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propylthiouracil-induced hepatotoxicity.
    Hardee JT; Barnett AL; Thannoun A; Eghtesad B; Wheeler D; Jamal MM
    West J Med; 1996 Sep; 165(3):144-7. PubMed ID: 8909171
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methimazole and propylthiouracil induced acute toxic hepatitis].
    Casallo Blanco S; Valero MA; Marcos Sánchez F; de Matías Salces L; Blanco González JJ; Martín Barranco MJ
    Gastroenterol Hepatol; 2007 May; 30(5):268-70. PubMed ID: 17493435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propylthiouracil-induced hepatotoxicity and death. Hopefully, never more.
    Malozowski S; Chiesa A
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3161-3. PubMed ID: 20610609
    [No Abstract]   [Full Text] [Related]  

  • 8. Propylthiouracil-induced hepatic damage.
    Ozenírler S; Tuncer C; Boztepe U; Akyol G; Alkim H; Cakir N; Kandílć U
    Ann Pharmacother; 1996 Sep; 30(9):960-3. PubMed ID: 8876856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-Induced Liver Injury: A Unique Presentation of Single-Dose Administration of Propylthiouracil.
    Weissman S; Rajaratnam NG; Qureshi N; Inayat F; Elias S
    J Investig Med High Impact Case Rep; 2020; 8():2324709620951323. PubMed ID: 32830568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dissociated cholestasis: an uncommon complication of thioamide therapy].
    Francés Artigas C; Nicolau Ramis J; Rivera Irigoín R; González Moreno J; Masmiquel Comas L
    Endocrinol Nutr; 2013; 60(6):340-2. PubMed ID: 23036935
    [No Abstract]   [Full Text] [Related]  

  • 11. [Two cases of serious hepatic injury caused by antithyroid drugs].
    Grzywa M; Orłowska-Florek R; Grzywa-Celińska A
    Endokrynol Pol; 2009; 60(5):396-400. PubMed ID: 19885811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propylthiouracyl-induced severe liver toxicity: an indication for alanine aminotransferase monitoring?
    Benyounes M; Sempoux C; Daumerie C; Rahier J; Geubel AP
    World J Gastroenterol; 2006 Oct; 12(38):6232-4. PubMed ID: 17036403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA focuses on drugs and liver damage: labeling and other changes for acetaminophen.
    Kuehn BM
    JAMA; 2009 Jul; 302(4):369-71. PubMed ID: 19622807
    [No Abstract]   [Full Text] [Related]  

  • 14. Propylthiouracil-induced severe hepatitis: a case report and review of the literature.
    Ichiki Y; Akahoshi M; Yamashita N; Morita C; Maruyama T; Horiuchi T; Hayashida K; Ishibashi H; Niho Y
    J Gastroenterol; 1998 Oct; 33(5):747-50. PubMed ID: 9773944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children.
    Rivkees SA; Szarfman A
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3260-7. PubMed ID: 20427502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute cholestatic hepatitis along with agranulocytosis: a rare side effect of carbimazole.
    Jain K; Chakrapani M; Smitha K
    Ann Afr Med; 2010; 9(2):102-4. PubMed ID: 20587933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Major adverse reactions to propylthiouracil in 586 cases of hyperthyroidism].
    Frenkel J; Téllez R; Reyes C; González G; Michaud P
    Rev Med Chil; 1993 Nov; 121(11):1289-94. PubMed ID: 8191137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism].
    Lian XL; Bai Y; Dai WX; Jin ZM; Zeng ZP; Guo ZS
    Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):442-6. PubMed ID: 15312442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study.
    Kim HJ; Kim BH; Han YS; Yang I; Kim KJ; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
    Am J Gastroenterol; 2001 Jan; 96(1):165-9. PubMed ID: 11197248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
    Akmal A; Kung J
    Expert Opin Drug Saf; 2014 Oct; 13(10):1397-406. PubMed ID: 25156887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.